NCT04022525View on ClinicalTrials.gov

Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

December 31, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Leflunomide 20Mg Tab

blood samples of rheumatoid patients will be collected for SNPs detection and drug assay

Trial Locations (1)

Unknown

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04022525 - Assessment of Leflunomide Efficacy and Hepatotoxicity in Patients With Rheumatoid Arthritis Through Pharmacokinetic and Genetic Approaches | Biotech Hunter | Biotech Hunter